Am J Transplant, Volume 20, Suppl 3 Archives - Page 50 of 223 - ATC Abstracts

2020 American Transplant Congress
Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients
P. Tabrizian¹, M. Holzner², V. Agopian³, R. Busuttil³, G. Sapisochin⁴, N. Mehta⁵, F. Yao⁵, J. Roberts⁶, S. Florman¹, M. E. Schwartz¹, T. Ivanics⁷, J. Emond⁸, B. Samstein⁹, R. Brown, MD, MPH⁹, M. Najjar¹⁰, W. Chapman¹¹, M. Doyle¹¹, K. Halazun⁹
¹Transplant, Mount Sinai Medical Center, New York, NY, ²Surgery, Georgetown University Hospital, Washington DC, MD, ³Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA, ⁴Transplant, Univeristy of Toronto, Toronto, ON, Canada, ⁵Transplant, UCSF, San Francisco, CA, ⁶Transplantation, UCSF, San Francisco, CA, ⁷Transplant, University of Toronto, Toronto, ON, Canada, ⁸Transplant, Columbia University Medical Center, New York, NY, ⁹Transplant, Weill Cornell Medical Center, New York, NY, ¹⁰Transplant, Columbia Medical Center, New York, NY, ¹¹Transplant, Washington University School of Medicine, St Louis, MO
*Purpose: Early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) carries a poor prognosis. We aimed to develop a risk score for early HCC…
2020 American Transplant Congress
Live Donor Liver Transplant Offers Higher Survival, Improved Quality of Liver and Lower Morbidity for Recipients with Low MELD Score
M. Black, J. Bayer, H. Fernandez, E. Martinez, G. McKenna, N. Onaca, R. Ruiz, G. Testa, A. Wall, T. Ma, G. Saracino, S. Asrani, A. Gupta
Baylor University Medical Center, Dallas, TX
*Purpose: The shortage of cadaveric liver grafts contributes to significant waitlist mortality. Patients with low MELD-Na score (
2020 American Transplant Congress
Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant
J. Banbury¹, T. Loosier¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…
2020 American Transplant Congress
Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients
S. J. Yusuf¹, H. Bheemreddy¹, A. Imtiaz², N. Krishnan³
¹Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, ²Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, ³Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
*Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…
2020 American Transplant Congress
BK Viremia: A Double Edged Sword – The Impact of Immunosuppression Reduction on Allograft Rejection
A. Szczepanik¹, A. Bixby¹, C. Burrelli¹, A. Padiyar², T. Srinivas², K. Chavin³
¹Pharmacy, University Cleveland Medical Center, Cleveland, OH, ²Nephrology, University Cleveland Medical Center, Cleveland, OH, ³Surgery, University Cleveland Medical Center, Cleveland, OH
*Purpose: BK viremia (BKV) increases the risk of renal allograft loss following transplant. Guidelines recommend reduction of immunosuppression (IS) after BKV diagnosis, however, the ideal…
2020 American Transplant Congress
Community Affluence Impacts Patient Survival Post Liver Transplantation
D. Jorgensen, A. Humar, C. Hughes, M. Molinari, A. Ganoza, S. Ganesh, A. Duarte-Rojo, A. Tevar
Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: Liver transplantation is an effective treatment for patients with end stage liver disease with excellent patients and grafts long term outcomes. Many recipient disease…
2020 American Transplant Congress
Comparison of Stanford Integrated Psychosocial Assessment for Transplantation Scores to Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant
J. Trofe-Clark¹, G. Malat¹, M. Norris¹, M. Bleicher², E. Smith³, D. Sawinski², R. Weinrieb⁴, R. Bloom²
¹Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, ²Renal Division, Univ of Pennsylvania, Philadelphia, PA, ³Social Work, Hosp of Univ of Pennsylvania, Philadelphia, PA, ⁴Pyschiatry, Univ of Pennsylvania, Philadelphia, PA
*Purpose: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) is a standardized, evaluation tool intended to assess psychosocial health in organ transplant candidates. The purpose…
2020 American Transplant Congress
Bariatric Surgery to Achieve Sufficient Weight Loss for Heart Transplant Candidacy: Results of a Systematic Review and Meta-Analysis
B. Orandi¹, J. Purvis¹, S. Mehta¹, M. Gray¹, S. Pamboukian¹, J. Tallaj¹, C. Hoopes¹, C. Lewis¹, N. Terrault², J. Locke¹
¹UAB, Birmingham, AL, ²USC, Los Angeles, CA
*Purpose: As the obesity epidemic grows, it can be expected that an increasing number of heart failure patients will be precluded from heart transplant based…
2020 American Transplant Congress
Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study
A. Alam, E. Dib, H. Zafar, J. Felius, S. Hall, S. Joseph
Cardiology, Baylor University Medical Center, Dallas, TX
*Purpose: Coronary allograft vasculopathy (CAV) continues to be a common cause of morbidity and mortality in heart transplant recipients. Little is known about the timing…
2020 American Transplant Congress
Impact of the 2015 LAS Revisions on Lung Candidates with Pulmonary Vascular Disease
K. Lindblad¹, R. Goff¹, K. Chan²
¹UNOS, Richmond, VA, ²University of Michigan, Ann Arbor, MI
*Purpose: On February 19, 2015 a major revision to the Lung Allocation Score (LAS) was implemented with the goal of more accurately reflecting waitlist urgency…